Spectrum Pharmacy Institute Celebrates First Anniversary
Spectrum Pharmacy Products celebrated the one-year anniversary of its compounding education center, Spectrum Pharmacy Institute, which offers compounding training for pharmacists and pharmacy technicians.
On May 23, 2018, Spectrum Pharmacy Products, a manufacturer and distributor of pharmaceutical compounding chemicals, equipment, and supplies, announced the one-year anniversary of its compounding education center, Spectrum Pharmacy Institute (SPI).
SPI offers hands-on, accredited compounding training for pharmacists and pharmacy technicians. The 42,000-square-foot facility is equipped with the latest classroom technology and fully-functional laboratories. Spectrum launched the Spectrum Pharmacy Institute in spring 2017 in New Brunswick, NJ.
According to Spectrum, the live, hands-on, accredited courses at SPI have doubled, including:
- Non-sterile compounding USP 795
- Sterile compounding USP 797
- Hazardous drug compounding USP 800
- Bioidentical hormone replacement therapy
- Pain management
- Veterinary compounding.
SPI teaches approximately 30 live courses per year and offers classes with continuing education credits in southern California. The center has also added online education courses covering several dozen topics in compounding training, according to Spectrum.
All SPI courses are accredited by the Ernest Mario School of Pharmacy at Rutgers University or the American College of Apothecaries.
Source: Spectrum Pharmacy Products
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
